M&T Bank
GDRX icon

M&T Bank’s GoodRx Holdings GDRX Stock Holding History

M&T Bank’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,668
Closed -$72.9K – 1526
2025
Q2 		$72.9K Hold
14,668
– – ﹤0.01% 1512
2025
Q1 		$64.7K Sell
14,668
-1,271
-8% -$5.96K ﹤0.01% 1492
2024
Q4 		$74.1K Buy
+15,939
New +$87.6K ﹤0.01% 1584

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

M&T Bank's GDRX Position: Q3 2025 in Review

M&T Bank sold out of GoodRx Holdings (GDRX) in Q3 2025, closing a stake of 14,668 shares — an estimated $72.9K sold.

M&T Bank first reported a position in GDRX in Q4 2024 and held it in 3 quarters. The position peaked at $74.1K in Q4 2024. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • M&T Bank reported no remaining GoodRx Holdings position as of Q3 2025 after selling out during the quarter.
  • M&T Bank sold 14,668 GoodRx Holdings shares in Q3 2025, an estimated $72.9K.
  • M&T Bank first reported a position in GoodRx Holdings in Q4 2024 and held it in 3 quarters.
  • M&T Bank's GoodRx Holdings position peaked at $74.1K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on M&T Bank's 13F filing for Q3 2025, filed 14 Nov 2025.